Zurich, SWITZERLAND \u2013 July 12, 2018 \u2013 Sequana Medical AG (\u201cSequana Medical\u201d), a commercial stage medical device company focused on the development of innovative treatment solutions for the management of liver disease, heart failure, malignant ascites and other fluid imbalance disorders, announces today the appointment of Kirsten Van Bockstaele as Chief Financial Officer, with immediate effect. Kirsten is a seasoned finance executive with extensive international experience in the healthcare industry.
\nKirsten joins Sequana Medical from Fagron (formerly Arseus), an international pharmaceutical compounding company. Within Fagron, she held a number of senior financial roles, most recently as Vice President of Finance, North America. In this role, Kirsten was responsible for creating and overseeing the company\u2019s financial strategy and policy, positioning Fagron\u2019s North American companies for growth. She also played a pivotal role in building out the North American headquarters, supporting the financial integration of acquisitions and assisting in redirecting the company\u2019s strategy.
\nKirsten previously served as Chief Financial Officer for Arseus Dental & Medical Solutions, where she was instrumental in the coordination, support and control of financial activities in key European countries. Her previous roles include Financial Controller at Omega Pharma and Audit Manager at PwC. Kirsten has a degree in Financial and Fiscal Sciences from the University of Antwerp, Belgium.
\n\u201cWe are delighted to welcome Kirsten to Sequana Medical. Kirsten brings significant industry experience and a proven track record of building and leading financial functions in the international healthcare sector,\u201d said Ian Crosbie, Chief Executive Officer, Sequana Medical. \u201cHer expertise and insights will be hugely valuable as we continue to strengthen the Company for long-term growth and expand commercialisation of the alfapump\u00ae system.\u201d
\n\u201cI am delighted to join Sequana Medical during this exciting time of growth,\u201d added Kirsten Van Bockstaele, Chief Financial Officer, Sequana Medical. \u201cSequana Medical is a true innovator in the management of liver disease, heart failure and other fluid imbalance disorders and I look forward to working with Ian and the team in continuing to bring improved treatment options to patients.\u201d<\/p>\n